|
1
|
Canalis E and Delany AM: Mechanisms of
glucocorticoid action in bone. Ann N Y Acad Sci. 966:73–81. 2002.
View Article : Google Scholar
|
|
2
|
Altman A, Hochberg Z and Silbermann M:
Interactions between growth hormone and dexamethasone in skeletal
growth and bone structure of the young mouse. Calcif Tissue Int.
51:298–304. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Allen DB: Growth suppression by
glucocorticoid therapy. Endocrinol Metab Clin North Am. 25:699–717.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xia X, Kar R, Gluhak-Heinrich J, et al:
Glucocorticoid-induced autophagy in osteocytes. J Bone Miner Res.
25:2479–2488. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Weinstein RS, Nicholas RW and Manolagas
SC: Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis
of the hip. J Clin Endocrinol Metab. 85:2907–2912. 2000.PubMed/NCBI
|
|
6
|
Jia J, Yao W, Guan M, et al:
Glucocorticoid dose determines osteocyte cell fate. FASEB J.
25:3366–3376. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Owen HC, Roberts SJ, Ahmed SF and
Farquharson C: Dexamethasone-induced expression of the
glucocorticoid response gene lipocalin 2 in chondrocytes. Am J
Physiol Endocrinol Metab. 294:E1023–E1034. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mushtaq T, Farquharson C, Seawright E and
Ahmed SF: Glucocorticoid effects on chondrogenesis, differentiation
and apoptosis in the murine ATDC5 chondrocyte cell line. J
Endocrinol. 175:705–713. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mizushima N, Levine B, Cuervo AM and
Klionsky DJ: Autophagy fights disease through cellular
self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Paglin S, Hollister T, Delohery T, et al:
A novel response of cancer cells to radiation involves autophagy
and formation of acidic vesicles. Cancer Res. 61:439–444.
2001.PubMed/NCBI
|
|
11
|
Cherra SJ 3rd, Kulich SM, Uechi G, et al:
Regulation of the autophagy protein LC3 by phosphorylation. J Cell
Biol. 190:533–539. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun Y and Peng ZL: Programmed cell death
and cancer. Postgrad Med J. 85:134–140. 2009. View Article : Google Scholar
|
|
13
|
Mushtaq T and Ahmed SF: The impact of
corticosteroids on growth and bone health. Arch Dis Child.
87:93–96. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Allen DB, Mullen M and Mullen B: A
meta-analysis of the effect of oral and inhaled corticosteroids on
growth. J Allergy Clin Immunol. 93:967–976. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Simon D, Lucidarme N, Prieur AM, Ruiz JC
and Czernichow P: Treatment of growth failure in juvenile chronic
arthritis. Horm Res. 58(Suppl 1): 28–32. 2002. View Article : Google Scholar
|
|
16
|
Touati G, Prieur AM, Ruiz JC, Noel M and
Czernichow P: Beneficial effects of one-year growth hormone
administration to children with juvenile chronic arthritis on
chronic steroid therapy. I Effects on growth velocity and body
composition. J Clin Endocrinol Metab. 83:403–409. 1998.
|
|
17
|
Bechtold S, Ripperger P, Muhlbayer D, et
al: GH therapy in juvenile chronic arthritis: results of a two-year
controlled study on growth and bone. J Clin Endocrinol Metab.
86:5737–5744. 2001.PubMed/NCBI
|
|
18
|
Allen DB, Julius JR, Breen TJ and Attie
KM: Treatment of glucocorticoid-induced growth suppression with
growth hormone. National Cooperative Growth Study. J Clin
Endocrinol Metab. 83:2824–2829. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sadeghi-Nejad A and Senior B: Adrenal
function, growth, and insulin in patients treated with corticoids
on alternate days. Pediatrics. 43:277–283. 1969.PubMed/NCBI
|
|
20
|
Lai HC, FitzSimmons SC, Allen DB, et al:
Risk of persistent growth impairment after alternate-day prednisone
treatment in children with cystic fibrosis. N Engl J Med.
342:851–859. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Baron J, Klein KO, Colli MJ, et al:
Catch-up growth after glucocorticoid excess: a mechanism intrinsic
to the growth plate. Endocrinology. 135:1367–1371. 1994.PubMed/NCBI
|
|
22
|
Annefeld M: Changes in rat epiphyseal
cartilage after treatment with dexamethasone and
glycosaminoglycan-peptide complex. Pathol Res Pract. 188:649–652.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kember NF and Walker KV: Control of bone
growth in rats. Nature. 229:428–429. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mehls O, Himmele R, Homme M, Kiepe D and
Klaus G: The interaction of glucocorticoids with the growth
hormone-insulin-like growth factor axis and its effects on growth
plate chondrocytes and bone cells. J Pediatr Endocrinol Metab.
14(Suppl 6): 1475–1482. 2001.PubMed/NCBI
|
|
25
|
Silvestrini G, Ballanti P, Patacchioli FR,
et al: Evaluation of apoptosis and the glucocorticoid receptor in
the cartilage growth plate and metaphyseal bone cells of rats after
high-dose treatment with corticosterone. Bone. 26:33–42. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chrysis D, Ritzen EM and Savendahl L:
Growth retardation induced by dexamethasone is associated with
increased apoptosis of the growth plate chondrocytes. J Endocrinol.
176:331–337. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Neufeld TP: Autophagy and cell growth -
the yin and yang of nutrient responses. J Cell Sci. 125:2359–2368.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tsujimoto Y and Shimizu S: Another way to
die: autophagic programmed cell death. Cell Death Differ. 12(Suppl
2): 1528–1534. 2005. View Article : Google Scholar : PubMed/NCBI
|
